FDA Inspection
Filipa Lynce, M.D.Filipa Lynce, M.D. – FDA Inspection, Oct 21, 2025
Record Details
This FDA Inspection record concerns Filipa Lynce, M.D., with an inspection on October 21, 2025, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 54276b1a-0cc1-4a74-9f0a-b9bc1f647c9d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1287944
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.50Ensuring compliance with plan and protocol
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Filipa Lynce, M.D.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| January 29, 2021 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Filipa Lynce, M.D.
- FDA Inspection 1135746 - 2021-01-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.